Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. [electronic resource]
Producer: 20050203Description: 9105-14 p. digitalISSN:- 0008-5472
- Adenocarcinoma -- pathology
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins
- Camptothecin -- administration & dosage
- Colonic Neoplasms -- drug therapy
- Drug Synergism
- Female
- HCT116 Cells
- Humans
- Irinotecan
- Janus Kinase 2
- Liver Neoplasms -- drug therapy
- Membrane Glycoproteins -- administration & dosage
- Mice
- Mice, Nude
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proteins -- metabolism
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins c-bcl-2 -- biosynthesis
- TNF-Related Apoptosis-Inducing Ligand
- Topoisomerase I Inhibitors
- Transfection
- Tumor Necrosis Factor-alpha -- administration & dosage
- Tumor Suppressor Protein p53 -- genetics
- X-Linked Inhibitor of Apoptosis Protein
- Xenograft Model Antitumor Assays
- bcl-X Protein
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.